drugset / Trial / NCT01578304

Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder

NCT01578304

RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy and safety after 12 weeks oral administration of Imidafenacin 0.1mg b.i.d versus Fesoterodine 4mg once daily for the urge incontinence and/or increased urinary frequency associated with urgency as may occur in patients with overactive bladder.

Timeline

Start
2010-12
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fesoterodine Other / unclassified 4 mg
Subject Imidafenacin Small molecule 0.1 mg Oral

Indications